PTSM: Pharmaceutical Technology Sourcing and Management-02-03-2016

Industry experts discuss recent industry consolidation and what the outsourcing market holds for 2016.

Expanded systems integration, serialization, and supply chain connectivity will enhance productivity and support counterfeit prevention.

Nanoscale catalysts and engineered nanoparticles show promise for API synthesis and delivery.

Hermes Pharma has commercially implemented hot-melt coating (HMC) technology at its production facility.

Novasep is building a new synthesis laboratory and adding capacity for kilogram-scale batches of synthetic molecules that are needed for biological testing and preclinical trials, at its Pennsylvania, US facility.

Vetter announces completion of multi-functional building for development service and IT functions.

Siemens and ADENTS develop joint solution for drug serialization challenges.

Planned expansion at Onyx Scientific add laboratories, GMP suites, and storage space.

GS1 US announces the expansion of its advisory services program to address industry needs.

FDA’s Center for Drug Evaluation and Research publishes a list of upcoming new and revised guidance documents for 2016.

SGS Life Sciences expands chemistry and microbiology testing services after acquisition of Quality Compliance Laboratories.

FDA issued a warning letter to Chan Yat Hing Medicine Factory for CGMP violations.

Aesica Pharmaceuticals, a global pharmaceutical contract development and manufacturing organization (CDMO), announced the strategic relocation of development and clinical manufacturing services from Nottingham to Queenborough. The new development center at Queenborough has more than twice the capacity of the existing one in Nottingham.

The collaboration will focus on development of novel molecules using SMARTag technology to couple different therapeutic modalities.

Patheon announced the appointment of Gilles Cottier as president of the company’s pharmaceutical development services.

Charles River Laboratories entered into a definitive agreement to acquire WIL Research.

FDA issues a Warning Letter to Cadila Healthcare Limited for cGMP violations.

With less than two years to meet the US deadline, both manufacturers and CMOs have to move quickly to implement serialization practices.